New Risk • Apr 13
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$601m free cash flow). Earnings have declined by 39% per year over the past 5 years. Revenue is less than US$1m (NT$13m revenue, or US$400k). Minor Risk Share price has been volatile over the past 3 months (9.1% average weekly change). Reported Earnings • Apr 05
Full year 2025 earnings released: NT$0.91 loss per share (vs NT$0.56 loss in FY 2024) Full year 2025 results: NT$0.91 loss per share (further deteriorated from NT$0.56 loss in FY 2024). Net loss: NT$181.5m (loss widened 61% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings. Ankündigung • Mar 10
Locus Cell Co., Ltd., Annual General Meeting, Jun 25, 2026 Locus Cell Co., Ltd., Annual General Meeting, Jun 25, 2026. Location: 1 floor no,152, sec.1 ta t`ung rd., sijhih district, new taipei city Taiwan New Risk • Mar 02
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$572m free cash flow). Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m (NT$5.2m revenue, or US$165k). Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). New Risk • Sep 18
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -NT$572m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$572m free cash flow). Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m (NT$5.2m revenue, or US$172k). Minor Risk Share price has been volatile over the past 3 months (7.4% average weekly change). New Risk • Aug 22
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 43% per year over the past 5 years. Revenue is less than US$1m (NT$2.4m revenue, or US$77k). Minor Risk Share price has been volatile over the past 3 months (6.2% average weekly change). New Risk • Mar 28
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 47% per year over the past 5 years. Revenue is less than US$1m (NT$1.0m revenue, or US$31k). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (6.0% average weekly change). Ankündigung • Mar 10
Locus Cell Co., Ltd., Annual General Meeting, Jun 20, 2025 Locus Cell Co., Ltd., Annual General Meeting, Jun 20, 2025. Location: 1 floor no,152, sec.1 ta t`ung rd., sijhih district, new taipei city Taiwan New Risk • Mar 01
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 47% per year over the past 5 years. Revenue is less than US$1m (NT$1.0m revenue, or US$32k). Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Ankündigung • Nov 16
Locus Cell Co., Ltd. Announces Committee Appointments On November 15, 2024, Locus Cell Co., Ltd. announced two additional independent directors to its audit committee. Name of the new position holder: Independent director, Bao-Huei Huang, Director of Tatung Company; Independent director, Chih-Cheng Wang, Professor, College of Law, Chinese Culture University. Reason for the change: By-election of independent directors. Effective date of the new member: November 15, 2024. Ankündigung • Sep 12
Locus Cell Co., Ltd. Announces Resignation of Kuan-Ling Lai as Natural-Person Director Locus Cell Co., Ltd. announced resignation of Kuan-Ling Lai as natural-person director. Resume of the previous position holder: Special Assistant to the Deputy Chairman, Tatung Company. Reason for the change:Busy on work. Effective date of resignation is September 10, 2024. Ankündigung • Aug 30
Locus Cell Co., Ltd. Announces Resignation of Fang-Chen Kao as Director, Effective August 30, 2024 Locus Cell Co., Ltd. announced that the resignation of natural-person director of the company the company's 2024 regular shareholders meeting. Title and name of the previous position holder: Director, Fang-Chen Kao. Resume of the previous position holder: Chairman of Yu Meng Biomedical Co., Ltd. The company received the resignation letter on August 29, 2024, and the effective date of resignation is August 30, 2024. Ankündigung • Jun 27
Locus Cell Co., Ltd. Appoints Kun-Ying, Tsai as Chief Operating Officer, Effective July 15, 2024 Locus Cell Co., Ltd. announced the board of directors has resolved to appoint a chief operating officer. Name, title, and resume of the new position holder: Mr. Kun-Ying, Tsai. Type of change: New replacement. Effective date: July 15, 2024. Reported Earnings • Apr 16
Full year 2023 earnings released: NT$0.48 loss per share (vs NT$0.27 loss in FY 2022) Full year 2023 results: NT$0.48 loss per share (further deteriorated from NT$0.27 loss in FY 2022). Net loss: NT$96.9m (loss widened 81% from FY 2022). New Risk • Mar 19
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 100% over the past year. Revenue is less than US$1m. Minor Risk Share price has been volatile over the past 3 months (6.4% average weekly change). Ankündigung • Mar 08
Locus Cell Co., Ltd., Annual General Meeting, May 24, 2024 Locus Cell Co., Ltd., Annual General Meeting, May 24, 2024. Location: 1F No. 152 Sec. 1 Datong Rd. Xizhi District, New Taipei City (Yi Yuan Garden, Fushin Hotel) New Taipei City Taiwan Agenda: To consider 2023 Business Report; Audit Committees Review Report on the 2023 Accounting Final Statements; Report on implementation of the Companys Sound Business Plan; Report on revision of certain articles in the Company; Ratification of the Business Report and Financial Statements for 2023; Ratification of the Loss Compensation Plan for 2023; and to discuss other matters. Ankündigung • Dec 29
Locus Cell Co., Ltd. Approves Establishment of Information Security Committee and Appoints First Committee Members Locus Cell Co., Ltd. approved the establishment of the Information Security Committee and appointed first committee members. Name of the new position holder: Wen-Yuan Lin, Kuo-Bin Lin, Chun-Nong Cheng, Shih-Chia Lin, Yeong-Sung Lin. Resume of the new position holder: Wen-Yuan Lin, Independent Director of Locus Cell; Kuo-Bin Lin, Independent Director of Locus Cell; Chun-Nong Cheng, Independent Director of Locus Cell; Shih-Chia Lin, Director and Chief Executive Officer of Locus Cell; Yeong-Sung Lin, Information Security Consultant of Locus Cell. Effective date of the new member is December 27, 2023. 